4
Changes in Ownership
Cullinan Therapeutics, Inc. Filed Acc 0000902664-25-004499
10% owner bought 248,749 shares at an average $8.46 ($2,103,912)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Lynx1 Capital Management LP 10% owner | 2025-10-14 | Purchase | +15,032 | $7.59 | $114,048 | 8,564,116 | I |
| Lynx1 Capital Management LP 10% owner | 2025-10-15 | Purchase | +51,500 | $7.94 | $409,049 | 8,615,616 | I |
| Lynx1 Capital Management LP 10% owner | 2025-10-16 | Purchase | +150,000 | $8.86 | $1,328,250 | 8,765,616 | I |
| Lynx1 Capital Management LP 10% owner | 2025-10-17 | Purchase | +32,217 | $7.84 | $252,565 | 8,797,833 | I |
| Open-market purchases · 248,749 sh · avg $8.46 · $2,103,912 | |||||||
Loading xslF345X05/ownership.xml…